Find a list of your saved stories here

Lawsuit: New TennCare rates endanger hemophilia patients


Save Story

Save stories to read later


Estimated read time: 2-3 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NASHVILLE, Tenn. (AP) — Pharmacies in Tennessee are accusing the state of breaking federal law and endangering people with bleeding disorders such as hemophilia by reducing reimbursements for prescription blood-clotting drugs through its Medicaid program.

Hemophilia is very rare, affecting about 20,000 people in the United States, according to the federal Centers for Disease Control and Prevention, and the drugs used to treat it are among the most expensive on the market, according to the Hemophilia Federation of America.

A lawsuit filed last week by specialty pharmacies and their wholesaler accuses TennCare of targeting clotting-factor pharmacies, based on a faulty survey, to save $12 million to $15 million annually.

"TennCare's voluntary decision to save money by singling out clotting factor has placed the bleeding disorder community in great danger," the lawsuit says.

TennCare spokeswoman Sarah Tanksley declined to comment, citing the pending litigation.

If the reimbursement rates that took effect April 1 aren't immediately blocked, at least seven specialty pharmacies that aid about half of TennCare's bleeding disorder patients will have to withdraw from serving them and close their Tennessee operations, the lawsuit says.

Many of these patients need preventive doses several times a week, plus daily doses if they experience a bleeding event. And unlike non-specialty outpatient drugs, clotting factor has complex dispensing and medication management requirements that drive up costs, the lawsuit says.

Patients who forgo clotting treatments risk deteriorating joints and otherwise avoidable joint and bone replacement surgeries due to microscopic bleeding from normal bodily movement, the lawsuit says.

"These pharmacies cannot afford to dispense clotting factor to patients if they are losing significant amounts of money with each dispense," says the lawsuit, filed in Davidson County Chancery Court by Hemophilia Preferred Care of Memphis, Inc., First Choice Home Infusion, LLC, InTouch Pharmacy LLC and Twelvestone Medical, Inc.; and wholesaler National Cornerstone Healthcare Services, Inc.

Hemophilia Preferred Care of Memphis, Inc. said it serves 17 TennCare enrollees who need the blood-clotting drugs. Just one of them needed 530,000 units of a particular clotting drug last year; the same amount this year would mean a $160,000 loss per month for the pharmacy, the lawsuit says.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
JONATHAN MATTISE

    SIGN UP FOR THE KSL.COM NEWSLETTER

    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast